Low brain DHA content worsens sensorimotor outcomes after TBI and decreases TBI-induced Timp1 expression in juvenile rats

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 89, Issue 2-3, 2013, Pages 97-105

  Russell, Kristin L ^a   Berman, Nancy E J ^a   Levant, Beth ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Docosahexaenoic acid; Juvenile; Matrix metalloproteinase; Sensorimotor; TIMP 1; Traumatic brain injury

Indexed keywords

DOCOSAHEXAENOIC ACID; GELATINASE A; GELATINASE B; GLIAL FIBRILLARY ACIDIC PROTEIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; DIET; ENZYME ACTIVITY; FEMALE; JUVENILE; LIPID BRAIN LEVEL; LONG EVANS RAT; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; NUTRITIONAL DEFICIENCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SENSORIMOTOR FUNCTION; SHAM PROCEDURE; TRAUMATIC BRAIN INJURY;

DOCOSAHEXAENOIC ACID; JUVENILE; MATRIX METALLOPROTEINASE; SENSORIMOTOR; TIMP-1; TRAUMATIC BRAIN INJURY;

ANIMALS; BRAIN; BRAIN INJURIES; DOCOSAHEXAENOIC ACIDS; FEEDBACK, SENSORY; MATRIX METALLOPROTEINASES; RATS; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

RATTUS;

EID: 84880581547     PISSN: 09523278     EISSN: 15322823     Source Type: Journal    
DOI: 10.1016/j.plefa.2013.05.004     Document Type: Article

References (74)

1. M. Faul, L. Xu, M. Wald, V. Coronado, Traumatic Brain Injury in the United States: Emergency Department Visits, Hospitalizations and Deaths 2002-2006, Atlanta (GA): Centers for Disease Control and Prevention, National Center for Injury Prevention and Control, 2010.
2. Anderson V., Brown S., Newitt H., Hoile H. Long-term outcome from childhood traumatic brain injury: intellectual ability, personality, and quality of life. Neuropsychology 2011, 25:176-184.
3. Davis A.S., Dean R.S. Assessing sensory-motor deficits in pediatric traumatic brain injury. Appl. Neuropsychol. 2010, 17:104-109.
4. Ylvisaker M., Todis B., Glang A., Urbanczyk B., Franklin C., DePompei R., Feeney T., Maxwell N.M., Pearson S., Tyler J.S. Educating students with TBI: themes and recommendations. J. Head Trauma Rehabil. 2001, 16:76-93.
5. National Institute of Neurologic Disorders and Stroke, Traumatic Brain Injury: Hope Through Research, National Institutes of Health, Bethesda, MD, 2002.
6. Pinto P.S., Poretti A., Meoded A., Tekes A., Huisman T.A. The unique features of traumatic brain injury in children. Review of the characteristics of the pediatric skull and brain, mechanisms of trauma, patterns of injury, complications and their imaging findings-part 1. J. Neuroimaging 2012, 22:e1-e17.
7. Maxwell W.L. Traumatic brain injury in the neonate, child and adolescent human: an overview of pathology. Int. J. Dev. Neurosci. 2012, 30:167-183.
8. Pinto P.S., Meoded A., Poretti A., Tekes A., Huisman T.A. The unique features of traumatic brain injury in children. review of the characteristics of the pediatric skull and brain, mechanisms of trauma, patterns of injury, complications, and their imaging findings-part 2. J. Neuroimaging 2012, 22:e18-41.
9. Prins M.L., Hovda D.A. Developing experimental models to address traumatic brain injury in children. J. Neurotrauma 2003, 20:123-137.
10. Salem N., Litman B., Kim H.Y., Gawrisch K. Mechanisms of action of docosahexaenoic acid in the nervous system. Lipids 2001, 36:945-959.
11. Shaikh S.R. Biophysical and biochemical mechanisms by which dietary N-3 polyunsaturated fatty acids from fish oil disrupt membrane lipid rafts. J. Nutr. Biochem. 2012, 23:101-105.
12. Khan S.A., Vanden Heuvel J.P. Role of nuclear receptors in the regulation of gene expression by dietary fatty acids (review). J. Nutr. Biochem. 2003, 14:554-567.
13. Serhan C.N., Yacoubian S., Yang R. Anti-inflammatory and proresolving lipid mediators. Annu. Rev. Pathol. 2008, 3:279-312.
14. Serhan C.N., Yang R., Martinod K., Kasuga K., Pillai P.S., Porter T.F., Oh S.F., Spite M. Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions. J. Exp. Med. 2009, 206:15-23.
15. Serhan C.N., Chiang N., Van Dyke T.E. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat. Rev. Immunol. 2008, 8:349-361.
16. Sinclair A.J. Long-chain polyunsaturated fatty acids in the mammalian brain. Proc. Nutr. Soc. 1975, 34:287-291.
17. Clandinin M.T., Chappell J.E., Leong S., Heim T., Swyer P.R., Chance G.W. Intrauterine fatty acid accretion rates in human brain: implications for fatty acid requirements. Early Hum. Dev. 1980, 4:121-129.
18. Clandinin M.T., Chappell J.E., Leong S., Heim T., Swyer P.R., Chance G.W. Extrauterine fatty acid accretion in infant brain: implications for fatty acid requirements. Early Hum. Dev. 1980, 4:131-138.
19. Simopoulos A.P. Evolutionary aspects of diet: the omega-6/omega-3 ratio and the brain. Mol. Neurobiol. 2011, 44:203-215.
20. Gordon N. Nutrition and cognitive function. Brain Dev. 1997, 19:165-170.
21. McNamara R.K., Carlson S.E. Role of omega-3 fatty acids in brain development and function: potential implications for the pathogenesis and prevention of psychopathology. Prostaglandins Leukot. Essent. Fatty acids 2006, 75:329-349.
22. N. SalemJr., T. Moriguchi, R.S. Greiner, K. McBride, A. Ahmad, J.N. Catalan, B. Slotnick, Alterations in brain function after loss of docosahexaenoate due to dietary restriction of n-3 fatty acids, J. Mol. Neurosci., 16 (2001) 299-307; discussion 317-221.
23. Orr S.K., Trepanier M.O., Bazinet R.P. n-3 Polyunsaturated fatty acids in animal models with neuroinflammation. Prostaglandins Leukot. Essent. Fatty acids 2012.
24. Javierre C., Vidal J., Segura R., Lizarraga M.A., Medina J., Ventura J.L. The effect of supplementation with n-3 fatty acids on the physical performance in subjects with spinal cord injury. J. Physiol. Biochem. 2006, 62:271-279.
25. Pan H.C., Kao T.K., Ou Y.C., Yang D.Y., Yen Y.J., Wang C.C., Chuang Y.H., Liao S.L., Raung S.L., Wu C.W., Chiang A.N., Chen C.J. Protective effect of docosahexaenoic acid against brain injury in ischemic rats. J. Nutr. Biochem. 2009, 20:715-725.
26. Huang W.L., King V.R., Curran O.E., Dyall S.C., Ward R.E., Lal N., Priestley J.V., Michael-Titus A.T. A combination of intravenous and dietary docosahexaenoic acid significantly improves outcome after spinal cord injury. Brain 2007, 130:3004-3019.
27. Bailes J.E., Mills J.D. Docosahexaenoic acid reduces traumatic axonal injury in a rodent head injury model. J. Neurotrauma 2010, 27:1617-1624.
28. Wu A., Ying Z., Gomez-Pinilla F. Omega-3 fatty acids supplementation restores mechanisms that maintain brain homeostasis in traumatic brain injury. J. Neurotrauma 2007, 24:1587-1595.
29. Yang D.Y., Pan H.C., Yen Y.J., Wang C.C., Chuang Y.H., Chen S.Y., Lin S.Y., Liao S.L., Raung S.L., Wu C.W., Chou M.C., Chiang A.N., Chen C.J. Detrimental effects of post-treatment with fatty acids on brain injury in ischemic rats. Neurotoxicology 2007, 28:1220-1229.
30. Homayoun P., Parkins N.E., Soblosky J., Carey M.E., Rodriguez de Turco E.B., Bazan N.G. Cortical impact injury in rats promotes a rapid and sustained increase in polyunsaturated free fatty acids and diacylglycerols. Neurochem. Res. 2000, 25:269-276.
31. Levant B., Ozias M.K., Jones K.A., Carlson S.E. Differential effects of modulation of docosahexaenoic acid content during development in specific regions of rat brain. Lipids 2006, 41:407-414.
32. Ozias M.K., Carlson S.E., Levant B. Maternal parity and diet (n-3) polyunsaturated fatty acid concentration influence accretion of brain phospholipid docosahexaenoic acid in developing rats. J. Nutr. 2007, 137:125-129.
33. Favreliere S., Barrier L., Durand G., Chalon S., Tallineau C. Chronic dietary n-3 polyunsaturated fatty acids deficiency affects the fatty acid composition of plasmenylethanolamine and phosphatidylethanolamine differently in rat frontal cortex, striatum, and cerebellum. Lipids 1998, 33:401-407.
34. Levant B., Zarcone T.J., Fowler S.C. Developmental effects of dietary n-3 fatty acids on activity and response to novelty. Physiol. Behav. 2010, 101:176-183.
35. Wainwright P.E. Issues of design and analysis relating to the use of multiparous species in developmental nutritional studies. J. Nutr. 1998, 128:661-663.
36. Reeves P.G., Nielsen F.H., Fahey G.C. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 1993, 123:1939-1951.
37. Onyszchuk G., Al-Hafez B., He Y.Y., Bilgen M., Berman N.E., Brooks W.M. A mouse model of sensorimotor controlled cortical impact: characterization using longitudinal magnetic resonance imaging, behavioral assessments and histology. J. Neurosci. Methods 2007, 160:187-196.
38. Bilgen M. A new device for experimental modeling of central nervous system injuries. Neurorehabil. Neural Repair 2005, 19:219-226.
39. Narayana P.A., Grill R.J., Chacko T., Vang R. Endogenous recovery of injured spinal cord: longitudinal in vivo magnetic resonance imaging. J. Neurosci. Res. 2004, 78:749-759.
40. Sherwood N.M., Timiras P.S. A Stereotaxic Atlas of the Developing Rat Brain 1970, University of California Press, Ltd, Berkeley, Los Angeles.
41. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1986, Academic Press, Inc., San Diego.
42. Cole J.T., Yarnell A., Kean W.S., Gold E., Lewis B., Ren M., McMullen D.C., Jacobowitz D.M., Pollard H.B., O'Neill J.T., Grunberg N.E., Dalgard C.L., Frank J.A., Watson W.D. Craniotomy: true sham for traumatic brain injury, or a sham of a sham?. J. Neurotrauma 2011, 28:359-369.
43. Wu J.C., Chen K.Y., Yo Y.W., Huang S.W., Shih H.M., Chiu W.T., Chiang Y.H., Shiau C.Y. Different sham procedures for rats in traumatic brain injury experiments induce corresponding increases in levels of trauma markers. J. Surg. Res. 2013, 179:138-144.
44. Russell K.L., Kutchko K.M., Fowler S.C., Berman N.E., Levant B. Sensorimotor behavioral tests for use in a juvenile rat model of traumatic brain injury: assessment of sex differences. J. Neurosci. Methods 2011, 199:214-222.
45. Fowler S.C., Birkestrand B.R., Chen R., Moss S.J., Vorontsova E., Wang G., Zarcone T.J. A force-plate actometer for quantitating rodent behaviors: illustrative data on locomotion, rotation, spatial patterning, stereotypies, and tremor. J. Neurosci. Methods 2001, 107:107-124.
46. Grossman K.J., Goss C.W., Stein D.G. Sickness behaviors following medial frontal cortical contusions in male rats. Behav. Brain Res. 2011, 217:202-208.
47. Schallert T., Fleming S.M., Leasure J.L., Tillerson J.L., Bland S.T. CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology 2000, 39:777-787.
48. Ye J., Coulouris G., Zaretskaya I., Cutcutache I., Rozen S., Madden T. Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction. BMC Bioinformatics 2012, 13:134.
49. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
50. Harris J.L., Reeves T.M., Phillips L.L. Injury modality, survival interval, and sample region are critical determinants of qRT-PCR reference gene selection during long-term recovery from brain trauma. J. Neurotrauma 2009, 26:1669-1681.
51. Abramoff M.D., Magalhaes P.J., Ram S.J. Image processing with ImageJ. Biophotonics Int. 2004, 11:36-42.
52. W.S. Rasband, ImageJ, National Institutes of Health, Bethesda, MD, USA, 1997-2012.
53. Coggeshall R.E. A consideration of neural counting methods. Trends Neurosci. 1992, 15:9-13.
54. Galli C., Trzeciak H., Paoletti R. Effects of dietary fatty acids on the fatty acid composition of brain ethanolamine phosphoglyceride: reciprocal replacement of n-6 and n-3 polyunsaturated fatty acids. Biochim. Biophys. Acta 1971, 248:449-454.
55. Werner C., Engelhard K. Pathophysiology of traumatic brain injury. Br. J. Anaesth. 2007, 99:4-9.
56. Kozul C.D., Nomikos A.P., Hampton T.H., Warnke L.A., Gosse J.A., Davey J.C., Thorpe J.E., Jackson B.P., Ihnat M.A., Hamilton J.W. Laboratory diet profoundly alters gene expression and confounds genomic analysis in mouse liver and lung. Chem. Biol. Interact. 2008, 173:129-140.
57. Wright L.L., Bell R.W., Schreiber H.L., Villescas R., Conely L. Interactive effects of parity and pup stress on the maternal behavior of Rattus norvegicus. Dev. Psychobiol. 1977, 10:331-337.
58. Whishaw I.Q., Kolb B. The Behavior of the Laboratory Rat: A Handbook with Tests 2005, Oxford University Press, New York, NY.
59. Levant B., Ozias M.K., Davis P.F., Winter M., Russell K.L., Carlson S.E., Reed G.A., McCarson K.E. Decreased brain docosahexaenoic acid content produces neurobiological effects associated with depression: interactions with reproductive status in female rats. Psychoneuroendocrinology 2008, 33:1279-1292.
60. Levant B., Ozias M.K., Carlson S.E. Diet (n-3) polyunsaturated fatty acid content and parity interact to alter maternal rat brain phospholipid fatty acid composition. J. Nutr. 2006, 136:2236-2242.
61. Levant B., Radel J.D., Carlson S.E. Decreased brain docosahexaenoic acid during development alters dopamine-related behaviors in adult rats that are differentially affected by dietary remediation. Behav. Brain Res. 2004, 152:49-57.
62. Levant B., Ozias M.K., Carlson S.E. Sex-specific effects of brain LC-PUFA composition on locomotor activity in rats. Physiol. Behav. 2006, 89:196-204.
63. Vancassel S., Blondeau C., Lallemand S., Cador M., Linard A., Lavialle M., Dellu-Hagedorn F. Hyperactivity in the rat is associated with spontaneous low level of n-3 polyunsaturated fatty acids in the frontal cortex. Behav. Brain Res. 2007, 180:119-126.
64. Sifringer M., Stefovska V., Zentner I., Hansen B., Stepulak A., Knaute C., Marzahn J., Ikonomidou C. The role of matrix metalloproteinases in infant traumatic brain injury. Neurobiol. Dis. 2007, 25:526-535.
65. Jia F., Pan Y.H., Mao Q., Liang Y.M., Jiang J.Y. Matrix metalloproteinase-9 expression and protein levels after fluid percussion injury in rats: the effect of injury severity and brain temperature. J. Neurotrauma 2010, 27:1059-1068.
66. Candelario-Jalil E., Yang Y., Rosenberg G.A. Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia. Neuroscience 2009, 158:983-994.
67. Gottschall P.E., Deb S. Regulation of matrix metalloproteinase expressions in astrocytes, microglia and neurons. Neuroimmunomodulation 1996, 3:69-75.
68. Strongin A.Y., Collier I., Bannikov G., Marmer B.L., Grant G.A., Goldberg G.I. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J. Biol. Chem. 1995, 270:5331-5338.
69. Brew K., Nagase H. The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. Biochim. Biophys. Acta 2010, 1803:55-71.
70. Pagenstecher A., Stalder A.K., Kincaid C.L., Shapiro S.D., Campbell I.L. Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states. Am. J. Pathol. 1998, 152:729-741.
71. Gomis-Ruth F.X., Maskos K., Betz M., Bergner A., Huber R., Suzuki K., Yoshida N., Nagase H., Brew K., Bourenkov G.P., Bartunik H., Bode W. Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1. Nature 1997, 389:77-81.
72. Gardner J., Ghorpade A. Tissue inhibitor of metalloproteinase (TIMP)-1: the TIMPed balance of matrix metalloproteinases in the central nervous system. J. Neurosci. Res. 2003, 74:801-806.
73. Hayakawa T., Yamashita K., Tanzawa K., Uchijima E., Iwata K. Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum. FEBS Lett. 1992, 298:29-32.
74. Jourquin J., Tremblay E., Bernard A., Charton G., Chaillan F.A., Marchetti E., Roman F.S., Soloway P.D., Dive V., Yiotakis A., Khrestchatisky M., Rivera S. Tissue inhibitor of metalloproteinases-1 (TIMP-1) modulates neuronal death, axonal plasticity, and learning and memory. Eur. J. Neurosci. 2005, 22:2569-2578.